# Citius Pharmaceuticals
 (stock symbol: CTXR) Logo in transparent PNG format

## Citius Pharmaceuticals
 Logo large

### Citius Pharmaceuticals
 Logo large Download PNG (97.28 KB)

![Citius Pharmaceuticals
 Logo large Download PNG (97.28 KB)](/img/orig/CTXR_BIG-36b4aa5c.png)

## Citius Pharmaceuticals
 Logo icon format

### Citius Pharmaceuticals
 Logo icon format Download PNG (16.59 KB)

![Citius Pharmaceuticals
 Logo icon format Download PNG (16.59 KB)](/img/orig/CTXR-2e557dbe.png)

## Citius Pharmaceuticals
 Logo large for dark backgrounds

### Citius Pharmaceuticals
 Logo large for dark backgrounds Download PNG (87.87 KB)

![Citius Pharmaceuticals
 Logo large for dark backgrounds Download PNG (87.87 KB)](/img/orig/CTXR_BIG.D-8728d5ef.png)

## Citius Pharmaceuticals
 Logo icon format for dark backgrounds

### Citius Pharmaceuticals
 Logo icon format for dark backgrounds Download PNG (16.38 KB)

![Citius Pharmaceuticals
 Logo icon format for dark backgrounds Download PNG (16.38 KB)](/img/orig/CTXR.D-f245ad44.png)

## About Citius Pharmaceuticals


Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

1. Website domain: citiuspharma.com
2. Employees: 15
3. Marketcap: $0.21 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
